Allergy

1. MICHILS A, Makhoul JP, Blekic N, Haccuria A, et al
   Continuous improvement of FEV(1) in severe eosinophilic asthmatics on anti-interleukin-5 therapy.
   Allergy. 2024 Apr 24. doi: 10.1111/all.16139.
   

   >> Share

   
   
2. NAIR P, Radford K, Nunomura S, Mukherjee M, et al
   Response of sputum periostin to anti-T2 biologics treatment in severe asthma.
   Allergy. 2024 Apr 23. doi: 10.1111/all.16131.
   

   >> Share

   
   

   
   Am J Respir Crit Care Med

3. AKSAMIT TR, Locantore N, Addrizzo-Harris D, Ali J, et al
   Five-Year Outcomes Among U.S. Bronchiectasis and Nontuberculous Mycobacterial Registry Patients.
   Am J Respir Crit Care Med. 2024 Apr 26. doi: 10.1164/rccm.202307-1165.
   

   >> Share

   
   
4. SHAHBAZI KHAMAS S, Van Dijk Y, Abdel-Aziz MI, Neerincx AH, et al
   Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA Study.
   Am J Respir Crit Care Med. 2024 Apr 22. doi: 10.1164/rccm.202312-2270.
   

   >> Share

   
   

   
   Arch Dis Child

5. BECKETT RS, Jagadish A, Carroll W, Gilchrist FJ, et al
   Quality improvement project assessing the feasibility of using canister weight to estimate remaining doses in a salbutamol pressurised metered-dose inhaler.
   Arch Dis Child. 2024;109:444-446.
   

   >> Share

   
   

   
   Clin Exp Allergy

6. PIOTIN A, Godet J, Domis N, de Blay F, et al
   Rhinoconjunctivitis severity induced by cat exposure influences early and late asthmatic responses: Evidence from an environmental exposure chamber.
   Clin Exp Allergy. 2024 Apr 25. doi: 10.1111/cea.14485.
   

   >> Share

   
   

   
   Eur Respir J

7. BLOOM CI
   Reply: Asthma and cardiovascular disease: the strength of triangulation.
   Eur Respir J. 2024;63:2400554.
   

   >> Share

   
   
8. TATTERSALL MC, Gangnon RE, Jarjour NN
   Asthma and cardiovascular disease: embracing disease heterogeneity is required.
   Eur Respir J. 2024;63:2400469.
   

   >> Share

   
   
9. 
   ERJ Podcast April 2024: Allergic bronchopulmonary aspergillosis.
   Eur Respir J. 2024;63:24E6304.
   

   >> Share

   
   

   
   J Allergy Clin Immunol

10. TANG M, Charbit AR, Johansson MW, Jarjour NN, et al
    Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma.
    J Allergy Clin Immunol. 2024 Apr 23:S0091-6749(24)00365.
    

    >> Share

    
    
11. OBER C, Joseph CLM, Novembre J
    Population descriptors in asthma and allergy research: Time to re-group.
    J Allergy Clin Immunol. 2024 Apr 18:S0091-6749(24)00363.
    

    >> Share

    
    

    
    J Asthma

12. CORRAL-BLANCO M, Diaz Campos RM, Pelaez A, Melero Moreno C, et al
    Beyond forced exhalation: impulse oscillometry as a promising tool for bronchial hyperresponsiveness evaluation.
    J Asthma. 2024;61:427-435.
    

    >> Share

    
    
13. REN X, Kong Y, Yu H, Dong A, et al
    YiQi GuBen capsule alleviates OVA-induced asthma through improving mitochondrial dysfunction.
    J Asthma. 2024 Apr 22:1-11. doi: 10.1080/02770903.2024.2303755.
    

    >> Share

    
    
14. ZHANG F, Weng X, Zhu J, Tang Q, et al
    Machine Learning and Bioinformatics Approaches to Identify the Candidate Biomarkers in Severe Asthma.
    J Asthma. 2024 Apr 22:1-31. doi: 10.1080/02770903.2024.2335562.
    

    >> Share

    
    

    
    J Investig Allergol Clin Immunol

15. DE LAS VECILLAS L, Quirce S
    The Multiple Trajectories of the Allergic March.
    J Investig Allergol Clin Immunol. 2024;34:75-84.
    

    >> Share

    
    

    
    Minerva Pediatr (Torino)

16. BRAHIM ERRAHMANI M, Aichi M, Menaa M
    Discriminant analysis and logistic regression on genetic history and environmental factors in children with asthma.
    Minerva Pediatr (Torino). 2024;76:236-244.
    

    >> Share

    
    
17. WANG Y, Wang G, Zhu L, Li X, et al
    Inappropriate prescription of intravenous antibiotics at a tertiary children's hospital in China.
    Minerva Pediatr (Torino). 2024;76:161-166.
    

    >> Share

    
    

    
    Pediatr Allergy Immunol

18. PAPADOPOULOS NG, Custovic A, Deschildre A, Gern JE, et al
    Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO.
    Pediatr Allergy Immunol. 2024;35:e14129.
    

    >> Share

    
    
19. CABRERA-PEREZ JS, Eigenmann P, Akenroye A
    Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)".
    Pediatr Allergy Immunol. 2024;35:e14128.
    

    >> Share

    
    

    
    Pediatr Pulmonol

20. BUENDIA JA, Salazar AFZ
    Genotype-driven asthma prescribing of inhaled corticosteroids and long-acting beta2-agonist: A cost-effectiveness analysis.
    Pediatr Pulmonol. 2024 Apr 25. doi: 10.1002/ppul.27037.
    

    >> Share

    
    
21. GUEYE-NDIAYE S, Tully M, Tsou PY, Amin R, et al
    The effect of adenotonsillectomy on asthma symptoms in the Pediatric Adenotonsillectomy Trial for Snoring (PATS).
    Pediatr Pulmonol. 2024 Apr 24. doi: 10.1002/ppul.27022.
    

    >> Share

    
    

    
    PLoS One

22. YU Z, He J, Chen Y, Zhou Z, et al
    Chronic obstructive pulmonary disease as a risk factor for sarcopenia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0300730.
    

    >> Share

    
    

    
    Respir Med

23. LAVORINI F, Usmani OS, Salvi S, Rote K, et al
    A narrative review on the Synchrobreathe: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
    Respir Med. 2023;219:107435.
    

    >> Share

    
    

    
    Respir Res

24. XIANG J, Liu B, Li Y, Ren Y, et al
    TFEB regulates dendritic cell antigen presentation to modulate immune balance in asthma.
    Respir Res. 2024;25:182.
    

    >> Share

    
    
25. FARINHA I, Heaney LG
    Barriers to clinical remission in severe asthma.
    Respir Res. 2024;25:178.
    

    >> Share

    
    
26. PINKERTON JW, Preite S, Piras A, Zervas D, et al
    PI3Kgammadelta inhibition suppresses key disease features in a rat model of asthma.
    Respir Res. 2024;25:175.
    

    >> Share

    
    
27. WAN R, Srikaram P, Xie S, Chen Q, et al
    PPARgamma attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap.
    Respir Res. 2024;25:174.
    

    >> Share

    
    
28. XIAO W, Chen YL, Du LY, Wu J, et al
    Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations.
    Respir Res. 2024;25:173.
    

    >> Share

    
    
29. ZHU Z, Zhao S, Li J, Wang Y, et al
    Development and application of a deep learning-based comprehensive early diagnostic model for chronic obstructive pulmonary disease.
    Respir Res. 2024;25:167.
    

    >> Share

    
    

    
    Rev Mal Respir

30. DARGENTOLLE G, Georges M, Beltramo G, Poisson C, et al
    [Adverse events in biologics for severe asthma].
    Rev Mal Respir. 2024 Apr 22:S0761-8425(24)00190.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share